InvestSMART

Imugene Limited (ASX: IMU) - Announcements

- Current share price for IMU : $0.047

ASX company news and announcements for Imugene Limited (IMU) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Imugene Limited (IMU) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Imugene Limited (IMU), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Imugene Limited (IMU)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$26 Application for quotation of securities - IMU 12 Nov 2021 5:05PM $0.580 $0.047 fallen by 91.90%
$26 Eureka Strategic Collaboration (supplementary announcement) 9 Nov 2021 7:26PM $0.605 $0.047 fallen by 92.23%
$26 Application for quotation of securities - IMU 5 Nov 2021 5:13PM $0.590 $0.047 fallen by 92.03%
$26 Investor Presentation Imugene Eureka Therapeutics 1 Nov 2021 8:35AM $0.495 $0.047 fallen by 90.51%
$26 Investor webinar Imugene & Eureka Therapeutics Collaboration 1 Nov 2021 8:20AM $0.495 $0.047 fallen by 90.51%
$26 Imugene and Eureka Therapeutics onCARlytics Collaboration 1 Nov 2021 8:11AM $0.495 $0.047 fallen by 90.51%
$26 Application for quotation of securities - IMU 29 Oct 2021 7:08PM $0.495 $0.047 fallen by 90.51%
$26 Application for quotation of securities - IMU 25 Oct 2021 5:57PM $0.475 $0.047 fallen by 90.11%
$26 Letter to IMUOB Optionholders 25 Oct 2021 5:34PM $0.475 $0.047 fallen by 90.11%
$26 Change in substantial holding - PH 22 Oct 2021 5:43PM $0.445 $0.047 fallen by 89.44%
$26 Change of Director's Interest Notice - PH 22 Oct 2021 5:40PM $0.445 $0.047 fallen by 89.44%
$26 Notice Under Section 708A 22 Oct 2021 5:36PM $0.445 $0.047 fallen by 89.44%
$26 Application for quotation of securities - IMU 22 Oct 2021 5:31PM $0.445 $0.047 fallen by 89.44%
$26 Quarterly Activities/Appendix 4C Cash Flow Report 22 Oct 2021 4:56PM $0.445 $0.047 fallen by 89.44%
$26 Proposed issue of securities - IMU 20 Oct 2021 6:09PM $0.450 $0.047 fallen by 89.56%
$26 FIRST PATIENT DOSED IN PHASE I CLINICAL TRIAL OF CHECKVACC 20 Oct 2021 12:42PM $0.440 $0.047 fallen by 89.32%
$26 Application for quotation of securities - IMU 15 Oct 2021 4:10PM $0.420 $0.047 fallen by 88.81%
$26 Notice of Annual General Meeting/Proxy Form 14 Oct 2021 7:34PM $0.410 $0.047 fallen by 88.54%
$26 Change of Director's Interest Notice - LR 11 Oct 2021 4:41PM $0.420 $0.047 fallen by 88.81%
$26 Application for quotation of securities - IMU 8 Oct 2021 12:15PM $0.440 $0.047 fallen by 89.32%
$26 Investor Presentation 5 Oct 2021 5:07PM $0.420 $0.047 fallen by 88.81%
$26 Corporate Governance Statement 4 Oct 2021 1:32PM $0.450 $0.047 fallen by 89.56%
$26 Appendix 4G 4 Oct 2021 1:31PM $0.450 $0.047 fallen by 89.56%
$26 Annual Report to shareholders 4 Oct 2021 1:30PM $0.450 $0.047 fallen by 89.56%
$26 Application for quotation of securities - IMU 1 Oct 2021 1:07PM $0.465 $0.047 fallen by 89.89%

526 - 550 of 1200 results

Page 22 of 48

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.